Welcome to Marsh and McLennan's Conference Call. Today's call is being recorded. 1st Quarter 2021 Financial Results and Supplemental Information were earlier this morning. They are available on the company's website at mmc.com. Please note that remarks made today may include forward looking statements, including certain expectations related to COVID-nineteen and other matters.
Forward looking statements are subject to risks and uncertainties, and a variety of factors may cause actual results to differ materially from those contemplated by such statements. For a more detailed discussion of those factors, please refer to our earnings release for this quarter into our most recent SEC filings, including our most recent Form 10 ks, all of which are available on the Marshfield Clinic website. During the call today, we may also discuss certain non GAAP financial measures. For a reconciliation of these measures to the most closely comparable GAAP measures, Please refer to the schedule in today's earnings release. I'll now turn this over to Dan Glaser, President and CEO of Marsh McLennan.
Thank you. Good morning and thank you for joining us to discuss our Q1 results reported earlier today. I'm Dan Glaser, President and CEO of Marsh and McLennan. Joining me on the call today is Mark McGivney, our CFO and the CEOs of our businesses, John Doyle of Marsh, Peter Hearn of Guy Carpenter, Martine Furlong of Mercer and Scott McDonald of Oliver Wyman. Also with us this morning is Sarah DeWitt, Head of Investor Relations.
Issued. Marsh McLennan had an outstanding start to 2021. Our first quarter results were excellent, and we are well positioned for a very good year. Even though the pandemic is ongoing, our underlying revenue growth of 6% is the highest in over 6 years and accelerated sequentially across every business. We also grew adjusted EPS by 21% and generated significant margin expansion.
Our business has proven resilient throughout the pandemic. With the global economy now beginning to turn the corner, we saw an acceleration in our growth. With 6% underlying growth to begin the year, We now expect full year 2021 underlying revenue growth to be at the high end of our 3% to 5% guidance range and possibly above. As we look ahead, the outlook for the U. S.
And many of the countries we operate in is encouraging. However, many parts of the world continue to suffer with high levels of infection and there is still a significant amount of uncertainty. GDP in the U. S. Was close to flat in the Q1 and strong levels of growth are expected starting in the second quarter due to a rebound in demand as the impact of vaccines takes hold along with favorable economic comparisons to a year ago.
Information remain a long way off. Our proprietary pandemic navigator now forecasts that the U. S. Will achieve the herd immunity threshold by early to mid summer, and we see a fairly similar timeline in the UK. These milestones bring hope for reopening and economic growth, although it will vary by country.
We are also mindful that the risks exist and that there still are many unknowns such as variants of the virus, the efficacy of vaccines on the variance, the duration of immunity and vaccine hesitancy, but we are resilient and are confident we will be able to adapt to a wide range of scenarios just as we have since the beginning of this crisis. Our colleagues are our single largest competitive advantage. We have world class talent that has delivered for clients and one another throughout the crisis. We continue to invest in hiring. We are an employer of choice for smart, hard working, talented individuals and are adding to what is already the deepest talent pool in the industry.
We are also pressing ahead with acquisitions. MMA made a significant acquisition on April 1, PayneWest. Pain West was one of the largest independent agencies in the U. S. With more than 700 employees in 26 locations.
The acquisition adds nicely to our geographic footprint in the middle market space and brings the Northwest hub. Overall, we are on track for a very good year. Demand for our advice and solutions is strong. The economy is recovering. In the Q1.
P and C insurance pricing remains firm and we are benefiting from industry disruption. Although the outlook remains uncertain, We are more optimistic than we were when we started the year and our efforts are focused on resurgence rather than recovery. At the end of the Q1, Marsh McLennan released our inaugural environmental, social and governance report. Truly great companies must deliver both exceptional financial performance and be good employers and global citizens, and we are working on many fronts to advance the interests of all of our stakeholders. We believe that starts with transparency.
Our report provides enhanced disclosure in a variety of ESG related areas from how we measure our own carbon footprint to how we use data to manage our workforce. For the first time, we provide gender, ethnic and racial diversity representation data at all levels of our organization and workforce maps that track talent flows and inform how and where we build and recruit talent. Our report highlights our commitment to a diverse and inclusive workplace. In 2020, we launched our Leading the Change initiative to underscore the need to continuously nurture our inclusive culture and serve the fundamental principles of human dignity, issued by the end of the quarter. We also strengthened our commitment to a better sustainable future through our pledge to be carbon neutral this year along with a commitment to reduce our carbon emissions by 15% by 2025.
Issued. ESG issues are among the most critical challenges facing our clients today. We are creating solutions for our clients related to complex business issues such as climate change, diversity and inclusion, affordable healthcare, cybersecurity and responsible investing. Marsh and Guy Carpenter are helping clients build resilience to flood risk and the documented increase in natural catastrophe perils witnessed in recent years. Marsh and Guy Carpenter's experience in the alternative energy space has sparked innovation and been the growth driver.
Marsh designed in place the first of its kind policy for a European utility, which set lower upfront premium payments based on the client's achievement of sustainability targets. Issued. Algo Wyman is actively advising its clients across sectors, including banking, energy, industrials and transportation, Imagine the risks and capturing the opportunities associated with climate change and the transition to a low carbon economy through a new climate and sustainability practice. Away from climate risk, Mercer is helping address the gender pay gap, diversity and inclusion in the workplace, the workforce of the future and consulting our new normal strategies in the wake of the pandemic. Overall, we see significant growth potential in the areas of ESG as well as an opportunity to benefit our clients, issued.
Let me spend a moment on current P and C insurance market conditions. The Q1 marks the 14th consecutive quarter of rate increases in the commercial P and C insurance marketplace. The Marsh Global Insurance Market Index showed price increases of 18% year over year versus 22% in the 4th quarter. The pace of price increases moderated sequentially in the Q1 after accelerating for 11 straight quarters. However, the 18% increase is still one of the highest since we started publishing the index in 2012.
Global property insurance was up 15% and global financial and professional lines were up 40%, while global casualty rates were up 6% on average and U. S. Workers' compensation rates were modestly negative. Keep in mind, our index skews to large account business. However, U.
S. Small and middle market insurance pricing continues to rise as well, although the magnitude of price increases is less than for large complex accounts. Turning to reinsurance, the Guy Carpenter's in the quarter. Global property catastrophe rate online index increased just under 5% at the January 1 reinsurance renewals. For the April 1 renewals, Japanese property catastrophe pricing increased for the 3rd year in a row, but at a more moderate pace versus prior years.
Meanwhile, pricing and terms and conditions in the U. S. On April 1 business were largely a continuation of the January 1 pricing environment. Capacity is more than adequate and demand remains high. However, reinsurance capacity remains constrained on all on certain lines of business, most notably for cyber risk.
Overall price increases continue to persist in both the P and C insurance and reinsurance markets. Low interest rates, elevated loss activity and continued uncertainty related to the pandemic present challenges for underwriters. Times of uncertainty underscore the need for for advice and solutions, and we are working hard to help our clients navigate these challenges. Now let me turn to our Q1 financial performance, which represents an excellent start to 2021. We generated adjusted EPS of $1.99 which is up 21% versus a year ago, driven by a combination of strong growth and the continuation of the suppressed environment for travel and entertainment expenses as we continue to operate largely remotely.
Total revenue increased 9% versus a year ago and rose 6% on an underlying basis. Underlying revenue grew 7% in RIS and 3% in consulting. Marsh grew 8% in the quarter on an underlying basis, the highest quarterly underlying growth since 2003 and benefited from double digit new business growth. Guy Carpenter grew 7% on an underlying basis in the quarter. Mercer underlying revenue was flat in the quarter, which showed sequential improvement from the 4th quarter.
Oliver Wyman underlined revenue grew by 11% as demand accelerated. Overall, the first in the quarter. The quarter saw adjusted operating income growth of 20% and our adjusted operating margin expanded 2 50 basis points year over year, reflecting positive operating leverage and favorable expense comparisons. As we look out for the remainder of 2021, We are well positioned given the strong demand for our advice and solutions and our expectation for an improving economic backdrop. As we mentioned, we now expect 2021 underlying revenue growth to be at the high end of our 3% to 5% range and possibly above.
We also expect to generate margin expansion and strong growth in adjusted EPS. Issued. As we mentioned last quarter, 2021 represents the 150th anniversary of Marsh McLennan. As we look back on our storied history, one theme runs through it all. This company steps up in the moments that matter.
At times of war and peace, in eras of transcendent innovation, in serving the public good. In March, we changed our name for Marsh and McLennan Companies to Marsh McLennan. It was a a small but important change that better reflects the way that our company has come together. 1 company with 4 global businesses united by a shared purpose to make a difference in the moments that matter. The challenges before us all are vast, issued.
If so are the possibilities, climate resilience, systemic risk, digital disruption, the protection gap, Affordable Health Care, the Future of Work. As we face this new world together, one thing will never change. In the quarter. Marsh McLennan will be at our client's side, finding opportunity and navigating uncertainty in the areas of risk, strategy and people. With that, let me turn it over to Mark for a more detailed review of our results.
Thank you, Dan, and good morning. Our Q1 results were outstanding, and we are well positioned for a very good 2021 despite the continued uncertainty associated with the pandemic. Underlined growth accelerated across all of our businesses, and our margin expansion and earnings growth were impressive. Consolidated revenue increased 9% in the Q1 to $5,100,000,000 reflecting underlying growth of 6%. Operating income and adjusted operating income were both approximately $1,400,000,000 Our adjusted operating margin increased 260 basis points to 29.6 percent.
GAAP EPS was 1.91 dollars and adjusted EPS was $1.99 up 21% compared with the Q1 a year ago. Issued. Looking at risk and insurance services. 1st quarter revenue was $3,200,000,000 up 11% compared with a year ago or 7% on an underlying basis. This marks the highest level of underlying growth since 2012.
Adjusted operating income increased 17 percent to $1,100,000,000 and our adjusted operating margin expanded 210 basis points to 36.6%. At Marsh, revenue in the quarter was $2,300,000,000 up 13% compared with a year ago or 8% on an underlying basis. This was Marsh's highest level of underlying growth in nearly 2 decades. Growth in the quarter was broad based and driven by double digit new business growth and solid retention and was impressive considering Marsh's strong growth in the in the Q1 of last year. The U.
S. And Canada division delivered another exceptional quarter with underlying revenue growth of 9%. This is the highest quarterly underlying growth U. S. And Canada has achieved since we began reporting their results, and they have now averaged 6% underlying growth over the last 12 quarters.
In international, underlying growth was strong at 6%, marking the highest underlying growth since 2013. EMEA was up 6% with strong results in each region, including in the UK. Asia Pacific was up 8%, a strong rebound from the 4th quarter and comes on top of 6% growth in the Q1 of 2020. And Latin America grew 6% on an underlying basis, continuing to show sequential improvement. Guy Carpenter's revenue was $895,000,000 up 8% or 7% on an underlying basis, driven by strong growth in North America, EMEA, Global Specialties and Latin America Treaty.
By Carpenter has now achieved 5% or higher underlying growth in 12 of the last 14 quarters. In the consulting segment, revenue in the quarter was $1,900,000,000 up 6% from a year ago or 3% on an underlying basis. Adjusted operating income was $370,000,000 and the adjusted operating margin expanded by 3 30 basis points to 20.5%. At Mercer, revenue in the quarter was $1,300,000,000 which was flat on an underlying basis. Mercer's top line performance improved each month in the Q1, and we expect Mercer to return to underlying growth in the 2nd quarter.
Wealth increased 1% on an underlying basis, reflecting strong growth in investment management, offset by a modest decline in defined benefit. Our assets under delegated management grew to approximately $380,000,000,000 at the end of the Q1, up 42% year over year were 6% sequentially, benefiting from net new inflows and market gains. Health underlying revenue was flat in the quarter, but faced a tough comparison to 8% growth in the Q1 of last year. And career grew 1% on an underlying basis, reflecting strong sequential improvement. At Oliver Wyman, revenue in the quarter was $585,000,000 an increase of 11% on an underlying basis.
1st quarter results were a continuation of the momentum we started to see materializing in the 4th quarter. Adjusted corporate expense was $57,000,000 in the quarter. Foreign exchange added approximately $0.06 to our adjusted issued. Soothing exchange rates remain at current levels, we expect FX to be a slight benefit in the Q2 with limited impact thereafter. Issued.
Our other net benefit credit was $71,000,000 in the quarter. For the full year 2021, we continue to expect our other net benefit credit will increase modestly year over year. Investment income was $11,000,000 in the Q1 on a GAAP basis for $10,000,000 on an adjusted basis and mainly reflects gains in our private equity portfolio. Interest expense in the Q1 was $118,000,000 compared to $127,000,000 in the Q1 of 2020, reflecting lower debt levels in the period. Based on our current forecast, we expect approximately $114,000,000 of interest expense in the second quarter.
Our effective adjusted tax rate in the Q1 was 24.3% compared to 23.2% in the Q1 last year. Our tax rate benefited from favorable discrete items, the largest of which would be accounting for share based compensation similar to a year ago. Excluding discrete items, our effective adjusted tax rate was approximately 25.5%. When we give forward guidance around our tax rate, we do not project discrete items, which can be positive or negative. Based on the current environment, it is reasonable to assume a tax rate between 25% 26% for 2021.
Our current outlook for 2021 assumes the global economy returns to growth in the second quarter with a strong recovery in the U. S. Based on this outlook and our strong first quarter performance, we now expect underlying revenue growth to be at the high end of our 3% to 5% underlying growth guidance and possibly above. We currently expect we will deliver margin expansion for the full year. But as you think through the quarterly cadence, to be a key contributor to our expectations.
Keep in mind, we have tough expense comparisons in the second and third quarters. This view is based on our outlook today, and it goes without saying that conditions could turn out materially different than our assumptions, which would affect our projection. Turning to capital management and our balance sheet. So far this year, we have completed our JLT related deleveraging, enhanced our short term liquidity flexibility and seen S and P, Moody's and Fitch restore our rating outlooks to stable. We ended the quarter with $11,300,000,000 of total debt, which was consistent with the level at December 31.
In April, we repaid $500,000,000 of senior notes scheduled to mature in July, taking advantage of a prepayment option. Issued. This repayment brought our debt down to $10,800,000,000 and completed our planned deleveraging, marking an important milestone for us. Our next scheduled debt maturity is in January of 2022 when $500,000,000 of senior notes will mature. Issued earlier this month, we entered into a new 5 year revolving credit agreement.
Under this new facility, we increased the credit available to $2,800,000,000 from $1,800,000,000 In addition, we increased the size of our commercial paper program and now have capacity to issue $2,000,000,000 up from $1,500,000,000 previously. We view these changes as prudent steps that enhanced our liquidity profile and provide additional flexibility. In the Q1, we resumed share repurchases, reflecting our strong financial position and outlook for cash generation. We repurchased 1,000,000 shares of our stock for $112,000,000 We continue to expect to deploy approximately $3,500,000,000 of capital in 2021 across dividends, debt reduction, acquisitions and share repurchases. Issued.
The ultimate level of share repurchases will depend on how the M and A pipeline develops. As we've consistently said, we favor attractive acquisitions over share issued as we do high quality acquisitions as the better value creator for shareholders and the company over the long term. Now that our deleveraging is behind us, we are back to our normal focus for capital management. Our capital management strategy reflects balance and supports our consistent focus on delivering solid performance in the near term, while investing for sustained growth over the long term. For the capital we generate and target to deploy, we prioritize reinvestment in the business, both through organic investments and acquisitions.
However, we also recognize that returning capital to shareholders generates meaningful returns for investors over time, and each year, we target raising our dividend and reducing our share count. Our cash position at the end of the Q1 was $1,100,000,000 Uses of cash in the quarter totaled $392,000,000 and included $237,000,000 for dividends, dollars 112,000,000 for share repurchases at $43,000,000 for acquisitions. Overall, we had an outstanding Q1, positioning us well to deliver strong growth in both underlying revenue and adjusted earnings in 2021. And with that, I'm happy to turn it back to Dan.
Thanks, Mark. Operator, we are ready to begin Q and A.
Thank you. In the interest of addressing questions from as many participants as possible, we would ask the participants to limit themselves to one question and one follow-up question. Our first question comes from Mike Zaremski with Credit Suisse. Your line is open.
Hey, great. Good morning. First question, Thinking about some of your comments about organic growth. So this quarter, clearly excellent 6%. I believe, Dan, you said that for the full year, you could potentially be over the guide.
And you also said you expected Mercer's organic growth levels to improve in 2Q. So If I understood correctly, then I think it implies that there might be some deceleration in parts of the business in later quarters. So maybe just kind of curious, were there any issued kind of one time items in nature or things we should be thinking about in the back half of the year that could show less positive momentum?
Sure, sure. So why don't I take that to begin with, and then I'll hand off to each of our business leaders, so they can talk a little bit about their growth prospects and how they looked at quarter and what they're looking at going forward. I would just start by saying we've got real momentum right now. I mean, the U. S.
Economy is getting stronger. The JLT integration is well behind us and the combined organization is emerging from the pandemic strong, focused and on our front foot. Issued. New business generation was terrific across the business and in particular at Marsh and Oliver Wyman. So when Scott and John issued.
Speak to you a little bit about their new business. But overall, retention was strong, growth was broad based. On the RIS side, pricing is a tailwind and we are benefiting from some disruption in flight to quality. That said, issued. Mike, there is nothing one off or unusual about our results.
So we're not really going to get into issued. In coming quarters, do we expect a deceleration? Obviously, as Mark was saying, We start to get some easier comps on the top line and some tougher comps on the expense line, but it will play itself out and we expect to have a very strong year. Why don't we start with Marsh and John to just talk about growth a little bit. John?
Thanks, Dan. Mike, as Dan noted, nothing particularly one off in nature about the growth in the quarter. I was very pleased with the start to the year. Mark gave a bit of an around the world view in his prepared remarks, but just a little bit more color. Specialty growth was particularly strong in the quarter in FinPro, in our private equity practice, construction and energy, also very, very strong results in the quarter.
We had good growth and benefits. Our MGA and Affinity operations also had a good quarter. So I was quite pleased with it. I think we executed well for sure. Dan talked about our new business.
The renewal line was strong as well. We were very, very focused in what's still a very difficult market for our clients. But I think we're positioned well. And as Dan noted, the economy is picking up in some important markets for us. There's still obviously some uncertainty, as Dan and Mark both, noted in the macros, but I'm very, very pleased with the start to the year.
Thanks, John. We're going to go to Peter for a couple of minutes. Guy Carpenter has grown considerably and consistently over a number of years now. But Peter, what are you thinking about growth right now?
Issued? Thanks, Dan. Mike, our model is consistent growth over a long period of time. I think we've demonstrated that, as Dan said. Issued.
We do benefit from the rate increases that are going on in the market, but the bulk of our income is coming from new business wins and it's well balanced across all of our businesses from North America, Latin America, Middle East, Asia Pac, Global Specialties, all have recognized strong growth in the Q1 and we see the same holding true for Q2. Now Q3s and Q4 tend to be very small quarters for us, so there's more volatility inherent in them. But over the past few years, we've shown once again that even with smaller quarters, based on the disciplined approach we had to new business and the approach of growing in any market condition, we've demonstrated our ability to grow.
Thanks, Peter. Mike, you mentioned Mercer. So Martine, you want to talk about growth at Mercer?
Yes. Sure, Dan. We're very pleased with our quarterly for quarter 1 2021 results, especially since we were facing a conversion of 5% growth the same quarter last year. We've seen increased demands in our services, sequential revenue growth month to month to month during the quarter and a return to growth actually in March. We know that during the pandemic, clients have postponed discretionary work due to uncertainty and also employment levels have dropped.
But now we expect tailwinds from economic and job growth, partially offset, of course, by the continued structural decline in defined benefit. But clearly, we see a return to growth for the rest of the year starting with Q2. In terms of demand, our investment business, investment management business in particular with lots of demand in the alternative space and ESG and DE and I team's investment opportunities is strong. We started the year with strong inflow, demand for digital solutions around the whole of the business is also strong. Health has been resilient through the pandemic, and we see lots of demand in our Darwin Health Platform and Global Benefit Management.
And we've seen quite a good uptick in career as well with demand for engagement surveys, transformation of the workplace, return to a new normal, the redefinition of the way to work. So overall, it looks like a strong rest of the year for MRSA.
Okay. Thanks, Martine. So we've often said however Wyman is a bit more sensitive to business confidence, economic outlook, etcetera. And their strong growth actually bodes very well for the company overall. But Scott, you want to talk a little bit about Oliver Wyman and how you see at least the quarter and the next couple of quarters?
Yes. Happy to round out on growth for us. So we had a really strong quarter as you saw. I think that is driven by business confidence across really all of our sectors, particularly strong growth in the U. S.
And Europe. Issued. And the growth was really widespread across all the types of business we do, whether that was a growth strategy, digital or technology transformation, some restructuring, and in new areas like climate and sustainability. So it felt really healthy. I think though, Mike, given the volatility in our business, it's just important to maintain a long term perspective.
And we continue to be able to think we can grow the business at mid to high single digits over the long term. In the shorter term, with the current robust demand, the strong new sales, combined with the weaker performance from last year, we may exceed that long term target in any quarter and possibly for the year overall.
Thanks, Scott. So Mike, I know that was a lot, but I figured there'd be a lot of questions on growth, and we might as well go around the horn and and hear from our business leaders. So anything else, Mike?
Yes, that was great. One last quick follow-up. I believe you Dan, you said the Marsh Pricing Index came in at 18%, down a little bit from 22% quarter over quarter. I think some investors may want to focus on that stat. So I just wanted to get maybe potentially some more color.
Pricing clearly is a tailwind. I know you said that, but I believe the majority and maybe vast majority of your revenues are on a fee basis. So I think the beta in terms of sensitivity to pricing, issued. It's not right it's not as influential as other brokers that are maybe more commission based. I'm trying to maybe If you can give any color around how to think about the deceleration in pricing.
Thanks.
Sure, sure. And then and Let's just be clear. We're on the client side of the table. So these are even at an 18% deceleration from 2022 in the quarter sequentially. These are trying times for our clients and Marsh brokers are working real hard to together the best package, the best solutions in the circumstances.
John, you want to talk a little bit about commission versus fee and the impact of the rating environment on your overall growth just in general terms?
Sure. Mike, about 60% of our revenue is commission based, but about 50% of Marsh's total revenue is exposed to P and C pricing, right? So we have commission in the benefit side as well in some markets. So as Dan noted, it's still a
very, very difficult market for our clients
and obviously an uneven economy for so many of our clients. And so our clients, of course, are adapting to that. Some in this market and certainly throughout 2020, we're choosing to retain some more risk, whether it's through higher retentions or lower limits. Our captive managed business is experiencing pretty strong growth as well as an indicator of maybe how our clients are reacting to the market. But it's still a difficult market.
The D and O market, the excess casualty market in the U. S. And the cyber markets remain the most challenging. On the other hand, the work comp pricing continues to be pretty favorable for our clients and was modestly down pricing was modestly down in that product area here in the United States. So the underwriting community is clearly concerned about elevated cat activity.
It was obviously a busy cat quarter in the United States in the Q1. They're worried about loss cost inflation, lower interest rates. But my expectations is that we'll continue to see some moderation of price increases throughout the rest of the year. Again, I expect prices to be up year over year, but I do expect them to be up somewhat less than they've been up in recent quarters.
Thanks, John. Next question, please.
Our next question comes from Elyse Greenspan with Wells Fargo. Your line is open.
Issued. Hi, thanks. Good morning. My first question, digging into another topic, issued. In your prepared remarks, you mentioned continued low T and E in the Q1.
Issued. You also mentioned, right, some tougher comps year over year. And then obviously, once we get towards herd immunity, right, we could start to see somewhat of a pickup in T and E, but can you just help us think through the expenses? Any sense of issued. How we should think about kind of run rate when we kind of get through COVID in terms of what days you can guide to kind of potentially keep on
an ongoing basis.
Sure, sure. So Elyse, many companies, including Marsh McLennan, reduced expenses significantly, particularly in the second and third quarter. And as you know, last year, we started coming back and had positive expense closed in the Q4 because we did some hiring and that sort of thing. The largest reductions were in T and E and our view is that will to be a gradual comeback. And we believe people will travel with more purpose and more forethought than pre pandemic, and we're certainly going to encourage that within the company.
We're going to try to get away from the anytime, anywhere, hop on an airplane culture and pause and say, okay, there are important times where you go visit a client or you go visit a market, that's absolutely to be sure. But we have proven that we can operate effectively remotely. And so we want to create that little bit of pause to say, can I do this via a remote access like a Zoom or a issued, etcetera? And so it also is important for us in terms of as we manage our carbon footprint going forward and it's important for other companies, I think, to act in a similar fashion. So now one thing that let's not lose sight of, Even though there may be some pressure, as some expenses start to come back as we go through the year, that's actually good news.
Issued. That means that the world is recovering, the economy is recovering, that means business is getting back to normal, that has growth implications for us. And longer term, issued. We've learned a lot during this pandemic period and we believe we can be a leaner, more agile organization And that has implications. That means that while the office is core to our culture and is a central part of how we operate, We know we can operate with more flexibility and more agility than we have done in the past.
And longer term, That has implications for our real estate expense, which are quite heavy. And so I would expect that we'll be able to get some savings there over time. Issued. You have another question, Elyse?
Yes. Thank you. And then my second question on the capital side of things, issued. You guys alluded to, right, you did one deal in the Q1. My sense is that we've kind of seen a little bit of a slowdown around some broker deals just as we I think the expectation, right, that we could see a pickup later on in the year under certainty around tax reform.
So I guess I wanted to see if you guys kind of agree with that when you're thinking through the capital plan for the year. And then did you say where we are in that $3,500,000,000 as of the end of the Q1?
Sure. So a couple of things and then I'll hand over to Mark. I mean, overall, just to bear in mind that PayneWest is April 1. So that was not a 1st quarter item, it's a beginning of the second quarter, but we wanted to call it out because it's an important acquisition for the company. Issued.
We've been at it for 150 years, and we have been acquiring firms for that entire period of time. Let's not forget Henry Marsh and Donald McLennan came together and formed Marsh McLennan. And We don't pay much attention to what's happening to the tax rate or capital gains or what interest rates are, because we're not looking for companies to combine with and to join us who really are just playing the economics. We issued. Cultivate relationships over long stretches of time, we almost always for our important acquisitions are in exclusive discussions with the other company.
And we're coming together because we see value on both sides. We can grow better together. We can serve clients better together, issued etcetera. And so I don't believe that we don't have a budget around acquisitions. We go through our process and what happens, happens as we go through.
But ultimately let me hand to Mark and he can talk about capital management more broadly and what we have available for this year and our expectations of how we would likely use it. But Mark?
Thanks, Dan. So, Elyse, let me just run you through. So we still expect, as you said, roughly $3,500,000,000 of capital this year, and I'll just run you through the math of how that breaks down. We've already spent the $500,000,000 that we had targeted on deleveraging. So as I mentioned earlier, issued.
We pulled forward our July debt repayment. Dividends will run around $1,000,000,000 and that leaves $2,000,000,000 of that $3,500,000,000 available for M and A and share repurchase. Dan mentioned that we closed Pain West, which was a chunky deal. And our M and A pipeline remains full. It's always hard to predict how much we'll actually do, but our hope is that we see a meaningful amount of M and A this year.
But we also expect that we will see a meaningful amount of share repurchase, at least enough to see our share count go down this year.
Issued. Our next question comes from Phil Stefano with Deutsche Bank.
Issued. Yes. Thanks. Good morning. In looking at the organic growth, I guess, for international in particular, I was surprised at the strength just given how it feels like the vaccination rates and the impact of COVID is still a bit of a headwind there.
I I was hoping you could talk about the potential that the different regions have to the rollout of the take up rate of issued. And how we think about economic development and it might be trailing. Could there be slowdowns coming as we see 4th waves That we're fortunately not going to get in the U. S.
I mean, we had good international growth overall in the company, issued both in Marsh, but also on OW and Guy Carpenter as well. And Mercer had sequential growth. So overall, I mean, I would also bear in mind that over the last couple of years, we've digested the biggest acquisition in our history and that had some headwind with us as well in terms of revenue growth and we've seen issued and disruption. So we've seen a nice comeback in places like Latin America and also in Asia Pac issued better than what we've been experiencing for the last year or so. But the big winner in terms of issued.
Turnaround was U. K. John, you want to talk about your business in the U. K. A little bit?
Sure, Dan. Issued. Phil, as you noted, there, of course, will be ups and downs on a global basis in any kind of normal economy. And obviously, We're still recovering and still in the pandemic. And as Dan noted in his prepared remarks earlier, but I was very, very pleased with our performance in the quarter in the U.
K. It's been a bit of a stress point for us over the last 18 months or issued. Some of it related to just indigestion from coming together with JLT and some headwinds there. But we saw good growth, a lot of it from our middle market in U. K.
Business, but also in the specialty areas I noted before, particularly strong growth in our financial lines business. The D and O market, as I said earlier, is difficult for our clients. Very, very meaningful cyber growth in the U. K. And construction and energy were off to a terrific start.
Issued elsewhere in the world, I think just another bright spot to point out, we saw very, very good new business growth in Australia. And so I was quite pleased with that. So yes, it was an improved performance by the international team, and we expect continued good momentum.
Anything else, Phil?
Yes. A follow-up on the M and A discussion from earlier. And Dan, you had mentioned when you buy things, you tend to be kind of the sole buyer at the table. I'm sure there's a political way to answer this, but I'm just going to be direct, so apologies. But Aon and Willis is going through a transaction and it feels like there's going to be some businesses issued that come out of this that ultimately need to be divested.
As I think about your global position, can you be involved in the process, right? Not whether or not you choose to be and anything is going to happen, but just given your size, is this a process you can be involved in? And can you take a look at kind of what's being shopped?
Issued by the end of the quarter. Concerns about having enough competitors in the marketplace. So it would be unusual for them to look to us as a possible answer. I mean, we're open They're all ideas, but ultimately, I think it's unlikely that we would be a participant in all the very small area in that kind of vein. Now having said that, there are plenty of very good high quality firms that we're in discussions with.
And so when we look at our M and A pipeline, we look over the course of years, not over the course of months, and we've got a very rich pipeline of companies that we're having discussions with. So we feel very good about our ability to continue to add to the strength. And I would just issued. Use that as a backdrop to growth in general. Like I we generally feel that underlying growth is the most important measure to evaluate the health of the overall organization.
So our focus is generally on underlying growth. But every once in a while, You have to look at GAAP. What's the company doing on an overall basis? And if I just look at RIS as an example, Q1 last year, we grew a a very big organization on a GAAP basis 20% and followed up in this Q1 by an 11% on top of the 20% on a GAAP basis. We are significantly growing the organization.
And on the consulting side, it was more like a 5 on GAAP last year followed by a 6 this year on GAAP. So we're having good underlying performance, but we're also having issued a much larger organization and growing a much larger organization. Next question please, operator.
Our next question comes from Jimmy Bhullar with JPMorgan. Your line is open.
Hi, Good morning. Most of my questions were answered about a couple of points. First on The deal environment, can you talk about competition for deals, especially sort of small and midsized deals? It seems like valuations have steadily gone up over the past few years. And then on pricing, you spoke about sort of a slowdown issued in reinsurance and a slowdown in overall in your index.
Can you talk a little bit in a little bit more detail about lines where you've
issued. Okay. So I'll talk about your M and A point and then I'll hand off to John and Peter Hearn, so they can talk a little bit about the rate environment in a little bit more depth, although that's really inside baseball. Issued. Ultimately, when we look at deals, as I mentioned before, we're not chasing any deals.
Your Conclusion that multiples have gone up over the last number of years is absolutely true. Multiples are higher, which means we should be more selective and it means that we should understand the pro form a calculations in a deep way issued because most of these organizations are private. So the pro form a results are far different than the actual results over the previous issued years and there can be a disconnect in terms of what expectations are versus the reality of a performing business. Now our goal is actually to buy high quality firms. That's our primary goal, firms that match our culture where there's good chemistry, where the leaders plan to stay in the business and keep growing the business.
And there are a number, it's still a very fragmented market and there are a number of small to midsized companies in which we're able to speak with to really recognize the value of Marshmoor Clennant. I mean, we can demonstrate the companies the amount of additional mega producers that are developed post acquisition by Marsh McLennan and existed pre acquisition. So joining Marsh McLennan is good for the production force of these companies and that is a That's our unique selling proposition. The capabilities and resources of the organization broadly enabled producers to be more successful than they otherwise would be. But John, you want to talk about rating environment and what's been moving around the most?
I keep it pretty high level and then we can move on to Peter on that. Sure, sure, Dan.
Issued Jimmy, I covered it before. What I would say is that in most geographies and in most major product lines, There was a slight moderation in the average price increase in the Q1 as compared to the Q4. It was pretty consistent. Issued. I would say is probably the most notable thing when you look at it on a line by line basis and country by country basis.
Issued. Prices on average again went from 22% to 18%. As we've shared in the past, this is issued. Our index skews to large accounts, the middle market pricing is more modest than that. I think the most notable quarter to quarter change issued was in cyber, where the average price increase actually doubled from the Q4 into the Q1 from high teens to mid-30s.
And so as you might expect, given the exposure environment there, our cyber sales are growing quite rapidly at the moment.
Thanks. Peter, do you have anything to add?
No, I will reflect much of what John says, Jimmy, in that reinsurance pricing has been reasonably consistent by line of business over the past several quarters. And I think its capacity is adequate, demand is high. As John said, airlines of business like Cyber have been more capacity constrained, but there's still capacity available at a price. And I think at the end of the day, the reinsurer approach to our client base has been reasonable and has been based on experience and exposure of the individual client. And so prices, I wouldn't say, have gone down.
I'd say prices have moderated, but that's based on capacity. But it's as a function of exposure and experience by client. It is not a broad based across the board rate increase for everybody regardless of how you performed.
Issued. Our next question comes from David Motemaden with Evercore ISI. Your line is open.
Hi, good morning. I had a question just on some of the disruption that the Aon Willis deal could be having in the marketplace as you look at teams and hiring. Maybe you could just talk about how that's progressing. And Dan, I think you talked about adding 500 issued people in headcount last quarter in terms of strategic hires. I was just wondering maybe to give an update on that this quarter and how you See that progressing throughout the
year? Yes. I mean, we expect to be a real employer of choice in the business. And issued. But we're a big company.
We've got 76,000 people. So whether we lose a team of 20 people or higher, issued? If 10 or 20 or 30 individuals, ultimately, it's not a huge needle mover for us, But it's a way for us to build our strength, build on the mountain of talent that we already have. The 500 net headcount increase in the 4th quarter didn't all come from Aon or Willis, although the majority did. And I think in the 1st quarter, we're up over 100 heads net from Aon and Willis.
And I would expect that kind of thing to continue. This is a competitive environment and I do believe working at Marsh and McLennan is a choice not just for companies going through consolidation, but for experts broadly within our industry. And then
I guess just another question, just taking a look at other operating expenses, Those were down quite a bit year over year. I think it was down 10.5% year over year versus basically flat last quarter, both against pre COVID comps. I guess I'm wondering, were there any timing or sort of delayed expenses this quarter outside of T and E or any sort of other sort of COVID related Expense reductions during the quarter.
Yes. No, the comparison is a bit different. Things like meetings, for example. Okay. Take the Q1.
What do you do when the year starts? You get together and you talk about growth. So that happened in 2020. It didn't happen in 2021, but so meetings, some advertising, some use of facilities, That sort of thing. But we're not really overly concerned about the expense comparisons.
We were always working to move our other operating expenses down. To me, the glory would be a nice solid chunky comp and bend ratio and a much lower other operating expense ratio. That's the kind of thing over time that we want to do. And we have all kinds of initiatives in the firm to try to reduce other operating expenses as a way to deliver better margin, but also to deliver better comp and bend ratios as well. And as you'll note, comp and bend ratios were up in the quarter.
And so that to me is a pretty good thing. Other operating expenses down, comp and bend flat or up. That's a pretty good result with delivering big margin expansion for shareholders as well. Issued. Next question please.
Our next question comes from Meyer Shields with KBW. Your line is open.
Issued. With a question for Peter. You've described, I think, consistently high reinsurance demand and solid capacity. Does the Florida the upcoming Florida reinsurance renewals, does that look any different than what we've seen so far in 1.1 and 4.1?
Issued. Dean, right over to you.
Yes. Thank you, Dan. Meyer, if we look The rest of the year and obviously June when is the next big renewal date. I think we have to separate Florida from the rest of our portfolio because it's a different animal in a lot of different ways, not only from a regulatory environment, not only from a capital environment, not only from a capacity environment, not only from a legal environment. So as we look out into the rest of the year, we anticipate that for the broad percentage of our portfolio, the pricing will remain consistent.
Again, as I just said, issued. It is based on individual client exposure and experience. Florida obviously has gone through quite a turbulent time, not only from a loss standpoint, but an underlying erosion of capital due to heightened litigation. What that's resulted in is demand is issued to be less because people are re underwriting their books of business to deal with some of the spikes and exposure that they have. But overall, I'd say that there's more than enough capacity in Florida.
And for the non frequency layers and more capacity layers, there'll be plenty of capacity and for the lower down higher risk layers pricing will go up. We're still unsure as to what the dimensions are. We're expecting mid to high single digits for loss experience, high loss experience. Issued and it's still wait and see. But a lot of the capital in Florida comes from 3rd party capital unlike the rest of our portfolio, save for our retro
issued. Okay. That's tremendously helpful. Thank you.
And then
I was hoping to slide in a question for John. When you look at the small account component of your domestic P and C business, can you talk about how that whether pricing or underwriting appetite has changed over the last 3
to 6
months? Sure, Meyer. Really in most market cycles, middle market to small commercial pricing just doesn't move with the same level of volatility that we see in the upper middle market and in large multinational accounts. And that this market cycle, really the last couple of years, it's issued quite consistent with that observation. We saw most of last year, small commercial issued.
And there is a bit of not every insurer looks at the market kind of the same way, but small to the lower end of the middle market. We saw low single digit price increases most of last year. It accelerated a bit, in the 4th quarter to mid single digit issued in the Q1 as well. What I would note issued in that segment where we do see more commission than we do in other parts of our business. Work comp though is a huge part of our business there.
And as I noted earlier, work comp pricing remains pretty favorable for our clients.
Thank you. I would now like to turn the call back over to Dan Glaser, President and CEO of Marsh and McLennan, for any closing remarks.
Thank you. Thank everybody. I thank everybody for joining us on the call this morning. I want to thank our 76,000 colleagues for your perseverance under trying circumstances. These are the moments when our clients need us most.
Thank you all very much and I look forward to speaking with you next quarter.
This concludes today's conference call. Thank you for participating. You may now disconnect.